DiaMedica Therapeutics | 4:持股变动声明-董事 O'Connor Daniel J.
DiaMedica Therapeutics | 3:首次持股声明-董事 O'Connor Daniel J.
DiaMedica Therapeutics | 8-K:重大事件
DiaMedica Therapeutics | 4:持股变动声明-董事 Giuffre Randall Michael
DiaMedica Therapeutics | 4:持股变动声明-董事 Parsons James T.
DiaMedica Therapeutics | 4:持股变动声明-董事 Giuffre Randall Michael
DiaMedica Therapeutics | 4:持股变动声明-董事 Kuntz Richard
DiaMedica Therapeutics | 4:持股变动声明-董事 Pilnik Richard D.
DiaMedica Therapeutics | 4:持股变动声明-董事 Semba Charles Pauling
DiaMedica Therapeutics | 10-Q:2024财年三季报
DiaMedica Therapeutics | 8-K:DiaMedica Therapeutics 提供最新业务并公布 2024 年第三季度财务业绩
DiaMedica Therapeutics | 10-Q:2024财年二季报
DiaMedica Therapeutics | 8-K:DiaMedica Therapeutics 提供最新业务并公布 2024 年第二季度财务业绩
DiaMedica Therapeutics | EFFECT:其他
DiaMedica Therapeutics | 424B3:募资说明书
DiaMedica Therapeutics | CORRESP:信函
DiaMedica Therapeutics | UPLOAD:其他
DiaMedica Therapeutics | S-3:特定交易注册声明
DiaMedica Therapeutics | SC 13G:超过5%持股股东披露文件-John Fichthorn(5.2%),Dialectic Life Sciences SPV LLC(5.1%)等
DiaMedica Therapeutics | D:发行公告